Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Novartis, Atlas Ventures Back Upstart IFM Therapeutics In $27M Raise
Venture Capital

Novartis, Atlas Ventures Back Upstart IFM Therapeutics In $27M Raise

by fiercebiotech.com posted 2years ago 247 views
<span style="line-height: 20.8px;">Atlas-incubated startup IFM Therapeutics has raised $27 million in a Series A round as it looks to begin clinical stage trials against cancer and inflammatory diseases.</span>

In this article